Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Demi Moore’s Wonderbelly Antacids Investment Lands Supporting Role In Her Promotional Posts
Separate NAD Review Rejects Dakota Nutrition’s Ingredient Tests, Again
Mar 18 2024
•
By
Malcolm Spicer
Wonderbelly Antacid claims, including post by Demi Moore, challenged by Tums marketer Haleon. • Source: Source: National Library of Medicine; Shutterstock
More from International
More from Geography